Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is It Too Late to Buy Novavax Stock?

TheMotleyFool

0 0

Anyone who bought Novavax (NASDAQ: NVAX) stock prior to 2020 and sold at the end of last year scored a big win. The stock surged more than 3,400% over the past two years because investors bet on the company's coronavirus vaccine candidate.

But in recent times, stock performance hasn't been so bright. Why? Investors lost interest in the biotech company when it fell behind in its regulatory requests.

Today, Novavax is back on the right track. It's won authorization in more than 35 countries and is awaiting a regulatory decision from the U.S. Does this mean it's a good time to buy shares? Or is top share performance a thing of the past? Let's find out.

Source Fool.com

Like: 0

NVAX

Share